than in the general population.' During recent years a dramatic decrease in both perinatal mortality and neonatal morbidity has occurred as a result of intensive treatment of diabetes during pregnancy. The incidence of congenital malformations, however, has remained essentially the same.2 The exact cause of this increase in malformations in diabetic pregnancies is not known, but experimental3 and clinical data4 show an association between congenital malformations and maternal hyperglycaemia in early pregnancy-the critical period with regard to fetal malformations., ' We report an association between the severity of maternal hyperglycaemia in early pregnancy as measured by blood haemoglobin Al, (HbA,c) values and the occurrence of fetal malformations in mothers with insulin dependent diabetes.
Patients and methods
Between April 1978 and December 1982 the maternal HbAjC value had been determined at least once before the end of the 15th week of gestation in 139 insulin dependent diabetic patients who gave birth after 24 weeks of gestation. Four of them had a twin pregnancy. In addition, a fetal malformation was observed in three cases of induced abortion where an early HbA,, determination had been carried out. In two of these cases preoperative ultrasound had detected the malformation. These cases were also included in the study, so that the total number of pregnancies was 142 and the total number of fetuses 146. The maternal diabetes was classified according to White, as modified by Pedersen.6 Thirty eight pregnancies were in women with class B disease, 45 in women with class C disease, 49 in women with class D disease, and 10 in women with class F disease. The mean maternal age at delivery was 27 3 years (range 19-39).
Principles of the management of pregnancy and delivery of insulin dependent diabetics at this hospital have been described.7 The patients were referred to the hospital between the sixth and 15th weeks of gestation and kept under the care of a specialist team of obstetricians and internists. Ultrasound examinations were performed to determine gestational age, number of fetuses, and fetal morphology and to monitor intrauterine growth. The infants were examined physically by neonatologists at least three times: at birth, at the age of 1 day, and on discharge from the hospital (not before seven days). If a congenital defect was found or suspected further diagnostic studies were carried out when necessary. Pregnancies were classified as (a) not complicated by malformation, (b) 
Results
A total 125 pregnancies were not complicated by fetal malformation. A malformed fetus or infant was observed in 17 pregnancies. In six cases the anomaly was classified as minor and in 11 cases as major (table I). The mean initial HbA,c value was significantly higher in the group with minor malformations (9 3 (SD 1 9)0/%) and the group with major malformations (9 6 (SD 1 8)0o) than in the group without malformations (8-0 (SD 1-4)°0); p<0 05 and p< 001, respectively.
The difference in HbAl, values between the groups with minor and major malformations was statistically not significant. In all 17 pregnancies complicated by a malformation the mean initial HbAlc value was 9 5 (SD 1 8)°o, which was significantly (p<0001) higher than in the group without malformations.
There was a significant positive relation (X2=119; p=0-001) between the maternal HbA1e value in early pregnancy and the occurrence of malformations (table II) . An initial HbA,C value of 10-00/ or more was associated with malformations in six out of 17 pregnancies (35-3o0); two of these were minor (11-80/) and four major malformations (23 5%). An -2) 1 (1-6) 2 (3 2) values in early pregnancy. This observation supports the hypothesis that during the first weeks of pregnancy, or possibly even before conception, maternal hyperglycaemia or other metabolic disturbances associated with hyperglycaemia may cause a large variety of malformations, ranging from minor and clinically insignificant to multiple and fatal. In our study fetal malformation was observed in 3500 of pregnancies in which the initial HbAlc value had been 10% or higher. This value is 10 SD above the mean during pregnancy in healthy controls.9 A similar result was reported by Miller et al.4 We emphasise, however, that owing to the methodological problems in measuring HbAlc" each laboratory should establish its own reference values. Studies on animals3 show that the increase in congenital malformations in diabetic pregnancies may be prevented by strict control of diabetic metabolism during organogenesis. A similar result in man was reported by Fuhrmann et al.12 They found only one malformation in the infants of 128 diabetic women subjected to scrupulous care before and during pregnancy. In 292 women of similar age and severity of diabetes and in whom strict control was begun only after eight weeks of gestation the number of malformed infants was 22 (p <0 01).
We have shown previously that a high maternal HbA1, value duiring the second trimester of pregnancy signals a patient at special risk of perinatal death.13 It seems that a high HbAic value in early pregnancy is associated with a clearly increased risk of fetal malformations. A diabetic woman of fertile age should be advised to avoid unplanned pregnancy. Measurement of HbAlc is a simple way to determine whether a patient's diabetes is under satisfactory control before pregnancy. Whether an intensified treatment of diabetes to achieve an improved metabolic control will actually decrease the number of fetal malformations in these patients has still to be established.
